U.S. Food et al., 1959-11-16: FDA application record for Cytoxan injection showing an original approval dated 16 November 1959 and Baxter Healthcare as current holder; a companion oral tablet NDA 012141 exists.
11/16/1959
HTML record, unpaginated
U.S. Food et al., 1959-11-16: FDA application record for Cytoxan injection showing an original approval dated 16 November 1959 and Baxter Healthcare as current holder; a companion oral tablet NDA 012141 exists. Funder/conflicts: n/a. Maker: current holder Baxter Healthcare; the 1959 sponsor is not named on the page. FDA classifies the 11/16/1959 approval as 'Type 2 – New Active Ingredient'. NCI's timeline lists cyclophosphamide (NSC 26271) as FDA-approved in 1959. The compound patent is US 3,018,302, assigned to Asta Werke (CHI-10). Study type: regulatory record.
